SCHEMBL24258561

SCHEMBL24258561

COC[C@H]1C[C@@H](n2cnc3c2ncn2ccnc32)[C@@H]1COP(=O)(S)OC[C@@H]1C[C@@H](F)[C@H](n2cnc3c(N)ncnc32)O1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BCHE P06276 2/20 0.42
▸ TAS1R3 Q7RTX0 2/20 0.40
▸ TAS1R1 Q7RTX1 2/20 0.40
▸ FHIT P49789 5/20 0.39
▸ P2RX3 P56373 2/20 0.38
▸ P2RX2 Q9UBL9 2/20 0.38
▸ NT5E P21589 1/20 0.38
▸ P2RY1 P47900 3/20 0.38
▸ SRC P12931 2/20 0.38
▸ P2RY2 P41231 2/20 0.38
▸ DNPH1 O43598 1/20 0.38
▸ PRKAB2 O43741 1/20 0.38
▸ TRPM2 O94759 1/20 0.38
▸ LDHA P00338 1/20 0.38
▸ ADRB2 P07550 1/20 0.38
▸ FBP1 P09467 1/20 0.38
▸ ADORA1 P30542 1/20 0.38
▸ PRKAG1 P54619 1/20 0.38
▸ PRKAA2 P54646 1/20 0.38
▸ PDE4D Q08499 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258668 0.93 TAS1R3 (0.42) BCHETAS1R3TAS1R1FHITP2RX3
SCHEMBL24258656 0.93 TAS1R3 (0.42) BCHETAS1R3TAS1R1FHITP2RX3
SCHEMBL24258669 0.85 TAS1R3 (0.42) BCHETAS1R3TAS1R1FHITP2RX3
SCHEMBL24444145 0.83 POLB (0.46) TAS1R3TAS1R1FHITP2RX3P2RX2
SCHEMBL24258606 0.81 POLB (0.42) BCHETAS1R3TAS1R1FHITP2RX3
SCHEMBL22571145 0.80 BCHE (0.53) BCHETAS1R3TAS1R1FHITP2RX3
SCHEMBL24258562 0.79 BCHE (0.42) BCHEFHIT
SCHEMBL22524142 0.77 BCHE (0.55) BCHETAS1R3TAS1R1P2RX3P2RX2
SCHEMBL24258560 0.76 NT5E (0.43) TAS1R3TAS1R1FHITP2RX3P2RX2
SCHEMBL24258563 0.75 FHIT (0.39) BCHETAS1R3TAS1R1FHITP2RX3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752516-B1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL MYERS SQUIBB CO (US) 2022-02-23 — — EP disclosed
Send feedback